Histone deacetylase inhibitor givinostat alleviates liver fibrosis by regulating hepatic stellate cell activation

Heming Huang(XinHua Hospital), Guangming Li(XinHua Hospital)
Molecular Medicine Reports
February 26, 2021
10.3892/mmr.2021.11944
Cited by 12

Related Papers

Histone deacetylase inhibitor givinostat attenuates nonalcoholic steatohepatitis and liver fibrosis
|Acta Pharmacologica Sinica|2021|26
Histone deacetylase inhibitor givinostat attenuates nonalcoholic steatohepatitis and liver fibrosis
|bioRxiv (Cold Spring Harbor Laboratory)|2020|2